Loading ...

pluronic P85-coated phenytoin poly(butylcyanoacrylate) nanoparticles colloid

Based on

1 Articles
2016 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(butylcyanoacrylate)

PBCA
Type Polymer
Formula
Role core
2

phenytoin sodium

PHT-Na PHT
Type Single Compound
Formula C15H11N2NaO2
Role loaded material
3

polyethylene oxide-polypropylene oxide-polyethylene oxide

pluronic P85
Type Polymer
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug release

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
female phenytoin-resistant Sprague-Dawley rat with lithium-pilocarpine-induced chronic temporal lobe epilepsy

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Product

pluronic P85-coated phenytoin poly(butylcyanoacrylate) nanoparticles colloid

Hydrodynamic diameter: ~ 170 - ~ 450 nm

Medium: water

Support: none

Method 2

Type: Physical formation
Source:
Product

pluronic P85-coated phenytoin poly(butylcyanoacrylate) nanoparticles colloid

Diameter: 250 nm

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Starting materials
  • phenytoin sodium
  • butyl ester of 2-cyano-2-propenoic acid
  1. h3n7Otf9
  2. Ygjtc69
  3. Zzioj
  4. qdrNZnKucx
  5. MfP4hMdbzyFBUM2Z
  6. EDB
Product

pluronic P85-coated phenytoin poly(butylcyanoacrylate) nanoparticles colloid

Hydrodynamic diameter: 262.92 - 273.08 nm

Medium: assay buffer

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial